
Gainers
- Verona Pharma plc (NASDAQ:VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD. The company also reported Q2 earnings results.
- eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR) shares surged 49.3% to $1.3405. eFFECTOR Therapeutics appointed Douglas Warner, M.D., as chief medical officer.
- ReTo Eco-Solutions, Inc. (NASDAQ:RETO) gained 47% to $1.0799 after the company announced its subsidiary REIT Ecological Technology has won the bid for the Longxi County Comprehensive Land Management and Logistics Zone EOD Project.
- BBQ Holdings, Inc. (NASDAQ:BBQ) gained 45.6% to $17.06 after the company announced MTY Food Group entered into a definitive merger agreement to acquire all of the outstanding shares of the company for $17.25 per share.
- Akanda Corp. (NASDAQ:AKAN) gained 45.6% to $1.3991. Akanda will supply Cansativa with premium indoor cannabis flower grown at its Sintra facility in Portugal.
- Helbiz, Inc. (NASDAQ:HLBZ) rose 38.8% to $2.2350 after jumping 115% on Monday.
- Tuesday Morning Corporation (NASDAQ:TUEM) rose 33.5% to $0.4811 after gaining around 68% on Monday.
- ZK International Group Co., Ltd. (NASDAQ:ZKIN) jumped 31.2% to $1.64. ZK International won a $75 million bid in 'high quality drinking water household project.'
- Mersana Therapeutics, Inc. (NASDAQ:MRSN) shares gained 30.9% to $6.87. Mersana Therapeutics announced a global collaboration that provides GSK plc an exclusive option to co-develop and commercialize XMT-2056.
- Atara Biotherapeutics, Inc. (NASDAQ:ATRA) gained 24.5% to $4.52 after reporting a profit for the second quarter.
- PubMatic, Inc. (NASDAQ:PUBM) jumped 22.8% to $21.81 after reporting strong quarterly results.
- Nielsen Holdings plc (NYSE:NLSN) surged 21.3% to $27.56. Nielsen postponed court and special meetings of shareholders to permit finalization of preliminary agreement between consortium and The WindAcre Partnership LLC.
- RumbleON, Inc. (NASDAQ:RMBL) gained 21.1% to $24.75 after the company reported better-than-expected Q2 results.
- Edgio, Inc. (NASDAQ:EGIO) jumped 19.5% to $3.3596 after the company reported better-than-expected Q2 results.
- Ambac Financial Group, Inc. (NYSE:AMBC) jumped 18% to $13.16 following upbeat Q2 results.
- ShockWave Medical, Inc. (NASDAQ:SWAV) gained 17.2% to $259.96 after the company reported better-than-expected Q2 EPS and sales results and raised FY22 sales guidance above analyst estimates.
- Tricida, Inc. (NASDAQ:TCDA) gained 17% to $12.64 following strong quarterly earnings.
- Heron Therapeutics, Inc. (NASDAQ:HRTX) jumped 16.8% to $4.17 after the company posted upbeat quarterly sales and raised FY22 net product sales guidance.
- Ontrak, Inc. (NASDAQ:OTRK) shares rose 16% to $0.7892. Ontrak recently reported closing of registered direct offering for aggregate gross proceeds of $4.0 million.
- Horizon Global Corporation (NYSE:HZN) gained 14.3% to $1.60 following Q2 results.
- Lemonade, Inc. (NYSE:LMND) shares rose 13.7% to $28.56 after the company reported better-than-expected Q2 results and issued sales guidance above estimates.
- AlloVir, Inc. (NASDAQ:ALVR) gained 13.4% to $7.96. The company recently released quarterly results.
- T2 Biosystems, Inc. (NASDAQ:TTOO) jumped 13.3% to $0.1472. T2 Biosystems said it will explore potential to develop rapid molecular diagnostic test for monkeypox virus.
- American Equity Investment Life Holding Company (NYSE:AEL) rose 12.1% to $40.62 after the company reported better-than-expected Q2 EPS and sales results.
- BIMI International Medical Inc. (NASDAQ:BIMI) shares gained 11.6% to $0.6851 after Fnu Oudom reported a stake of 44% in the company in a 13D filing.
- Qualys, Inc. (NASDAQ:QLYS) gained 10.6% to $141.05 after the company reported better-than-expected Q2 EPS and sales results and issued FY22 sales guidance above analyst estimates.
- PowerSchool Holdings, Inc. (NYSE:PWSC) jumped 10.4% to $17.08 after the company reported better-than-expected Q2 EPS and sales results. The company also issued Q3 and FY22 sales guidance above analyst estimates.
- Luminar Technologies, Inc. (NASDAQ:LAZR) gained 8.3% to $8.57 after the company reported better-than-expected Q2 sales results.
- Comstock Resources, Inc. (NYSE:CRK) jumped 7.7% to $15.99.
- GoodRx Holdings, Inc. (NASDAQ:GDRX) rose 7% to $8.30 after the company reported better-than-expected Q2 sales results.
- Principal Financial Group, Inc. (NYSE:PFG) gained 7% to $73.60 after the company reported better-than-expected Q2 adjusted EPS results. Additionally, Morgan Stanley raised its price target from $65 to $68.
- Enovix Corporation (NASDAQ:ENVX) rose 6.2% to $14.56 after declining around 5% on Monday. JP Morgan recently initiated coverage on Enovix with an Overweight rating and announced a price target of $20.
- Peraso Inc. (NASDAQ:PRSO) rose 6.1% to $2.61. Peraso recently received customer orders totaling $6.4 million for mmWave Fixed Wireless Access market.
- News Corporation (NASDAQ:NWSA) gained 5.5% to $18.33 after the company reported Q4 EPS results up year over year and better-than-expected sales results.
- Desktop Metal, Inc. (NYSE:DM) shares rose 5% to $2.7175 after posting better-than-expected Q2 sales.